Antine Uses

8 Topics Found
Hexalen Altretamine

Altretamine (trade name Hexalen), also called hexamethylmelamine, is an antineoplastic agent. It was approved by the U.S. FDA in 1990. Contents 1 Uses 2 Mechanism 3 Side effects 4 Interactions 5 See also 6 References Uses It is indicated for use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with cisplatin and/or alkylating agent-based combination.[1] It is not considered a first-line tr...

Altretamine Drug Index

Altretamine (trade name Hexalen), also called hexamethylmelamine, is an antineoplastic agent. It was approved by the U.S. FDA in 1990. Contents 1 Uses 2 Mechanism 3 Side effects 4 Interactions 5 See also 6 References Uses It is indicated for use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with cisplatin and/or alkylating agent-based combination.[1] It is not considered a first-line tr...

Novantrone Mitoxantrone

Mitoxantrone (INN, BAN, USAN; also known as Mitozantrone in Australia; trade name Novantrone) is an anthracenedione antineoplastic agent. Contents 1 Uses 2 Side effects 3 Mechanism of action 4 See also 5 References 6 External links Uses Mitoxantrone is used to treat certain types of cancer, mostly acute myeloid leukemia. It improves the survival rate of children suffering from acute lymphoblastic leukemia relapse.[1] The combination of mitoxantrone and prednisone is app...

Mitoxantrone Drug Index

Mitoxantrone (INN, BAN, USAN; also known as Mitozantrone in Australia; trade name Novantrone) is an anthracenedione antineoplastic agent. Contents 1 Uses 2 Side effects 3 Mechanism of action 4 See also 5 References 6 External links Uses Mitoxantrone is used to treat certain types of cancer, mostly acute myeloid leukemia. It improves the survival rate of children suffering from acute lymphoblastic leukemia relapse.[1] The combination of mitoxantrone and prednisone is app...

Panretin Alitretinoin

Alitretinoin, or 9-cis-retinoic acid, is a form of vitamin A. It is also used in medicine as an antineoplastic (anti-cancer) agent developed by Ligand Pharmaceuticals. It is a first generation retinoid. Ligand gained Food and Drug Administration (FDA) approval for alitretinoin in February 1999. Contents 1 Medical uses 1.1 Kaposi’s sarcoma 1.2 Chronic hand eczema 2 Adverse effects 2.1 Systemic use 2.2 Topical use 2.3 Contraindications 2.4 Interactions 2.5 Overdose 3 Mechanism of ...

Targretin Bexarotene

Bexarotene, sold under the brand Targretin, is an antineoplastic (anti-cancer) agent approved by the U.S. Food and Drug Administration (FDA) (December 1999) and the European Medicines Agency (EMA) (March 2001) for use as a treatment for cutaneous T cell lymphoma (CTCL).[1] It is a third-generation retinoid.[2] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Mechanism 6 Physical properties 7 History 8 References Medical uses...

Bexarotene Drug Index

Bexarotene, sold under the brand Targretin, is an antineoplastic (anti-cancer) agent approved by the U.S. Food and Drug Administration (FDA) (December 1999) and the European Medicines Agency (EMA) (March 2001) for use as a treatment for cutaneous T cell lymphoma (CTCL).[1] It is a third-generation retinoid.[2] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Mechanism 6 Physical properties 7 History 8 References Medical uses...

Alitretinoin Drug Index

Alitretinoin, or 9-cis-retinoic acid, is a form of vitamin A. It is also used in medicine as an antineoplastic (anti-cancer) agent developed by Ligand Pharmaceuticals. It is a first generation retinoid. Ligand gained Food and Drug Administration (FDA) approval for alitretinoin in February 1999. Contents 1 Medical uses 1.1 Kaposi’s sarcoma 1.2 Chronic hand eczema 2 Adverse effects 2.1 Systemic use 2.2 Topical use 2.3 Contraindications 2.4 Interactions 2.5 Overdose 3 Mechanism of ...

Can't find what you're looking for?